Moreover, DNA topoisomerase II inhibitor-related secondary acute leukemia usually has a shorter duration of approximately 2 years and is associated with MLL gene rearrangement.78 The incidence of secondary acute leukemia is higher compared with lineage switch. Here, KMT2A is linked to acute leukemia.